Status:
UNKNOWN
Toxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies
Lead Sponsor:
Sohag University
Conditions:
Toxoplasmosis
Eligibility:
All Genders
3-70 years
Phase:
NA
Brief Summary
Toxoplasmosis is one of the most common zoonotic diseases caused by the obligate intracellular parasite, T. gondii. It affects up to one-third of the world's population Horizontal transmission is most...
Eligibility Criteria
Inclusion
- This study will be conducted on a group of patients who are diagnosed as have hematological malignancies
Exclusion
- Patients with other non hematological malignancies.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05963295
Start Date
August 1 2023
End Date
February 1 2025
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt